Immunomodulatory effects of donor lympho
β
Robert J. Soiffer; Edwin P. Alyea; Jerome Ritz
π
Article
π
1995
π
John Wiley and Sons
π
English
β 546 KB
Recently, donor lymphocyte infusions have been successfully used to treat patients with CML who have relapsed following allogeneic bone marrow transplantation (BMT). Responses can be achieved in more than 6&70% of patients with stable phase CML without the need for the additional high dose cytotoxic